Barclays
AGN

Barclays’s Allergan plc AGN Stock Holding History

Barclays’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-149,900
Closed -$26.5M – 6563
2020
Q1 		$26.5M Sell
149,900
-54,600
-27% -$10.3M 0.02% 529
2019
Q4 		$39.1M Buy
204,500
+32,800
+19% +$5.92M 0.02% 608
2019
Q3 		$28.9M Sell
171,700
-41,800
-20% -$6.81M 0.02% 691
2019
Q2 		$35.7M Buy
213,500
+186,100
+679% +$25.8M 0.02% 625
2019
Q1 		$4.01M Sell
27,400
-99,200
-78% -$14.4M ﹤0.01% 1845
2018
Q4 		$16.9M Sell
126,600
-87,500
-41% -$14.3M 0.01% 831
2018
Q3 		$40.8M Buy
214,100
+23,900
+13% +$4.39M 0.03% 497
2018
Q2 		$31.7M Sell
190,200
-19,500
-9% -$3.13M 0.03% 560
2018
Q1 		$35.3M Buy
209,700
+115,000
+121% +$19.3M 0.03% 567
2017
Q4 		$15.5M Sell
94,700
-121,900
-56% -$21.9M 0.01% 944
2017
Q3 		$44.4M Buy
216,600
+138,700
+178% +$32.3M 0.05% 338
2017
Q2 		$18.9M Sell
77,900
-49,400
-39% -$11.6M 0.02% 631
2017
Q1 		$30.4M Sell
127,300
-29,200
-19% -$6.8M 0.03% 399
2016
Q4 		$32.9M Sell
156,500
-77,700
-33% -$16.1M 0.04% 389
2016
Q3 		$53.9M Sell
234,200
-31,000
-12% -$7.58M 0.06% 240
2016
Q2 		$61.3M Buy
265,200
+72,300
+37% +$16.7M 0.08% 212
2016
Q1 		$51.7M Sell
192,900
-170,877
-47% -$48.9M 0.08% 208
2015
Q4 		$113M Buy
363,777
+261,100
+254% +$77.7M 0.14% 127
2015
Q3 		$27.8M Buy
102,677
+24,100
+31% +$7.4M 0.03% 451
2015
Q2 		$23.8M Sell
78,577
-61,600
-44% -$18.4M 0.03% 571
2015
Q1 		$41.6M Sell
140,177
-171,416
-55% -$48.9M 0.05% 382
2014
Q4 		$80.1M Sell
311,593
-54,597
-15% -$13.6M 0.08% 211
2014
Q3 		$88.3M Buy
366,190
+254,178
+227% +$56.9M 0.08% 181
2014
Q2 		$25M Sell
112,012
-290,876
-72% -$60.2M 0.03% 586
2014
Q1 		$82.6M Sell
402,888
-162,812
-29% -$32.2M 0.09% 188
2013
Q4 		$95M Sell
565,700
-184,200
-25% -$28.8M 0.1% 169
2013
Q3 		$108M Buy
749,900
+433,600
+137% +$57.8M 0.13% 109
2013
Q2 		$39.9M Buy
+316,300
New +$35.8M 0.05% 327

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Barclays's AGN Position: Q2 2020 in Review

Barclays sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,151,403 shares — an estimated $735M sold.

Barclays first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $765M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Barclays reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Barclays sold 4,151,403 Allergan plc shares in Q2 2020, an estimated $735M.
  • Barclays first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Barclays's Allergan plc position peaked at $765M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.